Trump Administration Politicizes US Research
Analysis based on 7 articles · First reported Jun 12, 2026 · Last updated Jun 15, 2026
The proposed changes to research funding by the Trump administration could significantly curtail innovation in the United States, particularly in the biotechnology and pharmaceutical industries. This politicization of science may lead to delayed or unpursued discoveries, negatively impacting public health and the long-term competitiveness of U.S. research institutions.
The Trump administration is proposing significant changes to the rules governing how federal agencies, particularly the United States — National Institutes of Health, distribute research funding. These changes, spearheaded by United States — Office of Management and Budget director Russell Vought, would allow political appointees to override expert peer reviewers in grant approval and permit the termination of existing grants based on political priorities. This move is seen as a direct attack on the U.S. scientific infrastructure, threatening to politicize research, curtail academic freedom, and potentially lead to a decline in U.S. innovation and global scientific dominance. Experts like Carolyn Bertozzi and Shobita Parthasarathy warn of devastating repercussions for Americans' health and the integrity of the research enterprise.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard